» Articles » PMID: 20167701

Pathologic Classification of Diabetic Nephropathy

Abstract

Although pathologic classifications exist for several renal diseases, including IgA nephropathy, focal segmental glomerulosclerosis, and lupus nephritis, a uniform classification for diabetic nephropathy is lacking. Our aim, commissioned by the Research Committee of the Renal Pathology Society, was to develop a consensus classification combining type1 and type 2 diabetic nephropathies. Such a classification should discriminate lesions by various degrees of severity that would be easy to use internationally in clinical practice. We divide diabetic nephropathy into four hierarchical glomerular lesions with a separate evaluation for degrees of interstitial and vascular involvement. Biopsies diagnosed as diabetic nephropathy are classified as follows: Class I, glomerular basement membrane thickening: isolated glomerular basement membrane thickening and only mild, nonspecific changes by light microscopy that do not meet the criteria of classes II through IV. Class II, mesangial expansion, mild (IIa) or severe (IIb): glomeruli classified as mild or severe mesangial expansion but without nodular sclerosis (Kimmelstiel-Wilson lesions) or global glomerulosclerosis in more than 50% of glomeruli. Class III, nodular sclerosis (Kimmelstiel-Wilson lesions): at least one glomerulus with nodular increase in mesangial matrix (Kimmelstiel-Wilson) without changes described in class IV. Class IV, advanced diabetic glomerulosclerosis: more than 50% global glomerulosclerosis with other clinical or pathologic evidence that sclerosis is attributable to diabetic nephropathy. A good interobserver reproducibility for the four classes of DN was shown (intraclass correlation coefficient = 0.84) in a test of this classification.

Citing Articles

Finerenone Alleviates Over-Activation of Complement C5a-C5aR1 Axis of Macrophages by Regulating G Protein Subunit Alpha i2 to Improve Diabetic Nephropathy.

Li Z, Sun Z, Tang S, Zhao M, Chen M, Chang D Cells. 2025; 14(5).

PMID: 40072066 PMC: 11898422. DOI: 10.3390/cells14050337.


Global burden of chronic kidney disease due to diabetes mellitus, 1990-2021, and projections to 2050.

Ma X, Liu R, Xi X, Zhuo H, Gu Y Front Endocrinol (Lausanne). 2025; 16:1513008.

PMID: 40060381 PMC: 11885120. DOI: 10.3389/fendo.2025.1513008.


Roxadustat regulates the cell cycle and inhibits proliferation of mesangial cells via the hypoxia-inducible factor-1α/P53/P21 pathway.

Cheng Y, Yang Q, Feng B, Yang X, Jin H Front Cell Dev Biol. 2025; 13:1503477.

PMID: 40040789 PMC: 11876171. DOI: 10.3389/fcell.2025.1503477.


Clinical Impact of Glucose Levels on Patient Outcome after Transcatheter Aortic Valve Replacement.

Abu Khadija H, Alnees M, Gandelman G, Awwad M, Schiller T, Hamdan Y Rev Cardiovasc Med. 2025; 26(2):25336.

PMID: 40026524 PMC: 11868884. DOI: 10.31083/RCM25336.


Explainability of a Deep Learning-Based Classification Model for Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis.

Wester Trejo M, Sadeghi M, Singh S, Mahmoodian N, Sharifli S, Hruskova Z Kidney Int Rep. 2025; 10(2):457-465.

PMID: 39990883 PMC: 11843110. DOI: 10.1016/j.ekir.2024.11.005.